NCT01752075View on ClinicalTrials.gov

A Non-interventional, Observational Post-marketing Registry of Patients Treated With Revlimid (Lenalidomide) in Taiwan

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

January 1, 2011

Primary Completion Date

July 12, 2013

Study Completion Date

July 19, 2013

Conditions

Multiple Myeloma

Interventions

DRUG

Revlimid

The prescribing physician should prescribe and monitor REVLIMID therapy according to the guidance and recommended schedules given in the approved Taiwan package insert (PI).

Trial Locations (1)

Unknown

NTUH, Taipei